Previous studies evaluating serum LECT2 observed consistent results on whether LECT2 can be used to predict prognosis of acute liver failure, lower serum LECT2 is associated with better prognosis in adult acute liver failure patients (Slowik et al., 2019). The gene discussed is LECT2; the disease is acute liver failure.